| Literature DB >> 35634368 |
Yi Chen1, Saifeng Qiao1, Huiping Liu1, Huizhen Xing1, Pei Chen1.
Abstract
Cymbopogon citratus is an important functional food, widely used for flavoring in Africa and South America. In this study, a novel high-molecular-weight polysaccharide (CCP) from C. citratus was extracted, and its structural characteristics and anti-breast cancer activity in vitro were investigated. CCP contained both α and β configurations and mainly composed of galactose (36.89%), arabinose (23.97%), glucose (18.35%) and rhamnose (9.36%) with an average molecular weight of 1.98 × 106 Da. The main glycosyl residues of CCP detected by methylation analysis were 1,3,6-linked Galp, 1,3-linked Glcp, 1,5-linked Araf , T-Araf , and T-Rhap. In vitro experiments suggested that CCP significantly inhibited the proliferation of MDA-MB-231 cells, decreased the expressions of cyclin D1 and CDK4 and stocked cells at G0/G1 phase. Meanwhile, the typical morphological features of apoptotic cells were also observed. Combining with the consequences of Annexin V-FITC/PI staining, Hoechst 33258 staining and western blot analysis, CCP induced apoptosis of MDA-MB-231 cells by triggering the Fas/FasL-mediated death receptor pathway. Overall, these results provide a theoretical basis for the application of C. citratus polysaccharide as a potential anti-breast cancer agent in functional food and medicine.Entities:
Keywords: Cymbopogon citratus; Fas/FasL signaling pathway; anti-breast cancer activity; polysaccharide; structural characteristics
Year: 2022 PMID: 35634368 PMCID: PMC9130703 DOI: 10.3389/fnut.2022.911838
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1The HPGPC chromatograms (A) and UV-vis spectra (B) of CCP.
Figure 2The FT-IR spectra (A) and monosaccharide composition (B) of CCP.
Figure 31H (A) and 13C (B) NMR spectra of CCP.
Methylation analysis of CCP.
|
|
|
|
|
|
|---|---|---|---|---|
| 5.976 | T-Rha | 1,5-di-O-acetyl-6-deoxy-2,3,4-tri-O-methyl rhamnitol | 10.67 | 59, 72, 89, 102, 118, 131, 145, 162, 175, 211 |
| 6.243 | T-Ara | 1,4-di-O-acetyl-2,3,5-tri-O-methyl arabinitol | 15.26 | 71, 87, 102, 118, 129, 145, 161 |
| 10.965 | 5-Ara | 1,4,5-tri-O-acetyl-2,3-di-O-methyl arabinitol | 9.76 | 59, 87, 102, 118, 129, 162, 189, 232 |
| 11.806 | 4-Xyl | 1,4,5-tri-O-acetyl-2,3-di-O-methyl xylitol | 4.49 | 71, 87, 103, 118, 129, 149, 162, 189, 205 |
| 12.573 | 3-Glc | 1,3,5-tri-O-acetyl-2,4,6-tri-O-methyl glucitol | 18.33 | 59, 87, 101, 118, 129, 161, 202, 234 |
| 13.264 | 3-Gal | 1,3,5-tri-O-acetyl-2,4,6-tri-O-methyl galactitol | 4.51 | 59, 87, 101, 118, 129, 161,174, 243 |
| 14.154 | 6-Man | 1,5,6-tri-O-acetyl-2,3,4-tri-O-methyl mannitol | 4.62 | 71, 87, 99, 102, 118, 129, 162, 189, 233 |
| 15.906 | 6-Gal | 1,5,6-tri-O-acetyl-2,3,4-tri-O-methyl galactitol | 8.03 | 71, 87, 99, 102, 118, 129, 162, 189, 233 |
| 19.389 | 3, 6-Gal | 1,3,5,6-tetra-O-acetyl-2,4-di-O-methyl galactitol | 24.36 | 59, 87, 101, 118, 129, 160, 189, 234 |
Figure 4(A) Effect of CCP on MDA-MB-231 cells proliferation. The morphological characteristics (B) and nuclear morphological changes (C) of cells treated with CCP. The white arrows represent apoptotic nuclear fragments. **P < 0.01 and ***P < 0.001 vs. control group.
Figure 5The scatter (A) and column (B) showed the Annexin V-FITC/PI staining results. The DCFH-DA staining results (C) and quantitative analysis (D) of the intracellular ROS.
Figure 6Distribution (A) and proportions (B) of treated cell in various phases of the cell cycle. The expressions levels (C) and quantitative analysis (D) of cyclin D1 and CDK4. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. control group.
Figure 7(A) Western blot assay for FasL, FADD, Fas, caspase-3, cleaved-caspase-3, caspase-8 and cleaved-caspase-8 protein expression levels. (B) Columns represent the expression of the FasL, FADD, Fas, caspase-3, cleaved-caspase-3, caspase-8 and cleaved-caspase-8 relative to β-actin. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. control group.
Figure 8The proposed molecular mechanisms of cell cycle arresting and apoptosis induced by CCP in MDA-MB-231 cells.